Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hingwastak Churna is a classical Ayurvedic polyherbal formulation traditionally used for the management of gastrointestinal disorders. It is composed of eight primary ingredients: Ferula assa-foetida (Hing), Trachyspermum roxburghianum (Ajamoda), Cuminum cyminum (Jeera), Nigella sativa (Kala Jeera), Zingiber officinale (Ginger), Piper nigrum (Black Pepper), Piper longum (Long Pepper), and Rock Salt (Saindhava Lavana). The formulation acts as a carminative and digestive stimulant, primarily by balancing the Vata and Kapha doshas. It enhances the secretion of digestive enzymes and gastric juices, reduces intestinal gas formation, and improves appetite. It is commonly indicated for dyspepsia, flatulence, abdominal colic, and anorexia. In India, it is regulated under the AYUSH framework and is widely available as an over-the-counter traditional medicine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hingwastak churna.